For 5-amino-1MQ specifically: Preclinical studies have not prominently described heart rate elevation as a dominant signal The mechanism (NNMT inhibition, NAD+ preservation) does not have the same direct cardiac implications as nuclear receptor agonism Human cardiovascular data at clinically relevant exposures are limited For physicians, the current evidence base does not support a major cardiovascular safety flag, but the limited human dataset means confident statements are premature
in Metabolism used a similar protocol and found smaller but directionally consistent results, with the strongest effect in participants who started with metabolic syndrome
Primary benefits include tendon and ligament healing, gut health support, and anti-inflammatory effects, mainly shown in preclinical research
How IGF-1 LR3 differs from regular IGF-1 The differences between natural IGF-1 and the LR3 variant go beyond half-life
They are not for human consumption, medical use, veterinary use, or household use
Alatassi adds, weight-loss drugs are no different than the medicines you might take to manage high blood pressure or diabetes
